Search the Newsreel

Ipca Laboratories shares gain over 2% to Rs 1,802.60

Rep. Mike Kelly Unloads Abbott Laboratories (NYSE:ABT) Shares

Representative Mike Kelly sold shares of Abbott Laboratories (NYSE:ABT) valued between $1,001 and $15,000 on July 17th, as well as shares of PepsiCo and Walt Disney on the same day. This sale occurred despite Abbott Laboratories reporting a quarterly earnings beat and reaffirming its …

Atour Lifestyle (ATAT) to Announce Quarterly Earnings on Thursday

Atour Lifestyle (NASDAQ:ATAT) is scheduled to announce its Q2 2026 earnings before market open on Thursday, August 20th. Analysts are anticipating an EPS of $0.57 and revenue of $476.76 million. The company previously surpassed expectations in its last quarter, and Wall Street maintains a …

Bio Rad Laboratories (BIO) Issues Flat Revenue Guidance, Is It Too Far Above Fair Value?

Bio-Rad Laboratories (BIO) has seen a sharp increase in its stock price over the last 90 days, despite recent flat revenue guidance and a significant long-term decline in shareholder return. The company is currently trading above its fair value estimate of $293, driven by …

Atmos Energy (ATO) Q3 2026 Earnings Call Transcript

Analysts Offer Insights on Healthcare Companies: Atossa Therapeutics (ATOS), Corvus Pharmaceuticals (CRVS) and Perspective Therapeutics (CATX)

This article highlights bullish sentiments from analysts on three healthcare companies: Atossa Therapeutics (ATOS), Corvus Pharmaceuticals (CRVS), and Perspective Therapeutics (CATX). Maxim Group maintained a Buy rating for Atossa, Mizuho Securities reiterated a Buy for Corvus, and LifeSci Capital also maintained a Buy for …

Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?

IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected …

5 Revealing Analyst Questions From Kratos’s Q2 Earnings Call

5 Revealing Analyst Questions From Kratos's Q2 Earnings Call Kratos' second quarter results drew a notably positive market response, with leadership attributing the strong performance to accelerated demand across its hypersonics, jet engine, and defense support businesses. CEO Eric DeMarco highlighted the company's alignment …

Vale Base Metals to Proceed with Coarse Particle Flotation at Salobo Increasing and Accelerating Projected Copper Production

Coarse Particle Flotation (CPF) expected to add up to ~30,000 tonnes of annual copper production and 6 million tonnes of annual ore processing capacity at Salobo Project start-up accelerated to first half of 2028; Construction license received CPF capex estimate optimized; Wheaton Precious Metals …

Silicon Labs (SLAB) Stock Carries A Premium As Losses Persist

Silicon Laboratories (SLAB) stock remains highly valued despite continuing to report net losses and negative basic earnings per share. While Q2 2026 results showed narrowed losses and increased revenue driven by IoT segments, concerns persist regarding the company's profitability and execution risk, especially with …

Mike Kelly makes multiple trades including Abbott Laboratories and Disney stocks

Congressman Mike Kelly recently executed several trades through the Victoria Kelly Trust ICA, including selling stocks from Abbott Laboratories and The Walt Disney Company, each valued between $1,001 and $15,000. He also sold Pepsico, Inc. stocks worth $15,001 to $50,000. Additionally, Kelly purchased government …

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

ABBOTT LABORATORIES AKTIE: AI-Analysen, Prognose & Kursziel

Dolby Laboratories (DLB) VP Nicholson sells 1,348 Class A shares at $62.04

Ryan Nicholson, VP, CAO and Corporate Controller of Dolby Laboratories (DLB), sold 1,348 shares of Class A common stock at $62.04 per share on August 10, 2026. Following this transaction, Nicholson directly holds 35,636 shares, which includes 19,303 shares of restricted stock units that …

Labcorp president & CEO Adam Schechter sells $1.5m in company stock

Adam H. Schechter, President & CEO of Labcorp Holdings Inc., sold 4,669 shares of company stock for approximately $1.5 million. The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan. This transaction occurred as LH stock traded near its 52-week high, following …

Insider Selling: Labcorp (NYSE:LH) CEO Sells 4,669 Shares of Stock

Labcorp CEO Adam Schechter sold 4,669 shares of company stock for approximately $1.50 million under a pre-arranged trading plan, reducing his total ownership by 4.35%. This sale occurred while Labcorp shares traded near their 52-week high, following strong quarterly earnings that surpassed analyst expectations. …

Dev Accelerator Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Kratos (KTOS) Stock Is Up, What You Need To Know

Kratos (KTOS) Stock Is Up, What You Need To Know What Happened? Shares of aerospace and defense company Kratos (NASDAQ:KTOS) jumped 2.5% in the afternoon session after the company announced its target systems were successfully used in a joint missile defense exercise with the …

The Abbott Big Ten $1 Million Blood Drive is Back

The Abbott Big Ten $1 Million Blood Drive returns for its third year, with Nebraska aiming to reclaim the title from Wisconsin. The competition, which runs from August 26th to December 4th, encourages donations to help address a national blood crisis, with a $1 …

Maxim Group Maintains Atossa Therapeutics(ATOS.US) With Buy Rating, Maintains Target Price $10

Maxim Group has reiterated its Buy rating for Atossa Therapeutics (ATOS.US) and maintained its price target of $10. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Labcorp Holdings (LH) is in focus after a series of oncology diagnostics approvals and launches, including the PGDx elio tissue complete CDx for advanced …

Atmos Energy (NYSE:ATO) Director Acquires $50,277.00 in Stock

Atmos Energy Director William James Ware recently purchased 300 shares of the company's stock for $50,277.00, increasing his ownership by over 159% to 488 shares. This acquisition comes as Atmos Energy's stock trades near its 52-week low, despite the company exceeding quarterly EPS expectations. …

Ind-Swift Laboratories Sets Q1 FY27 Earnings Call for August 17

Atmos Energy (ATO) director adds 300 shares in open-market stock purchase

Atmos Energy (ATO) director William James Ware purchased 300 shares of common stock on August 11, 2026, at $167.5945 per share in an open-market transaction. Following this acquisition, Ware directly

What Abbott Laboratories (ABT)'s AI-Powered Google Health Partnership Means For Shareholders

Abbott Laboratories has partnered with Google Health to integrate glucose insights from its Lingo biowearable into the Google Health app, using AI for personalized metabolic health coaching and unified wellness data. This collaboration includes a large-scale metabolic health study, potentially supporting Abbott's diabetes franchise …

Charles River Laboratories stock hits 52-week high at $285.13 By Investing.com

Charles River Laboratories International Inc. (CRL) stock has reached a 52-week high of $285.13, reflecting an 83.28% increase over the past year and a 41.4% year-to-date return. This surge follows strong second-quarter earnings that surpassed analyst expectations and led to increased price targets from …

Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Todd Spencer Chief Executive Officer - Birgit Girshick Executive Vice President and Chief Financial Officer - Glenn Coleman Full Conference Call Transcript …

Wall Street Analysts See a 66.12% Upside in Kratos (KTOS): Can the Stock Really Move This High?

Kratos (KTOS) closed the last trading session at $63.73, gaining 26.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of …

CAPLIPOINT: Strong revenue growth, margin expansion, and strategic investments drive future outlook

Every 2 Seconds, Someone in the U.S. Needs Blood as Abbott Drive Returns

Abbott (NYSE: ABT) and the Big Ten Conference have relaunched their "We Give Blood" nationwide competition to address a critical blood supply crisis in the U.S. All 18 Big Ten universities will compete to generate the most blood donations, with Abbott awarding $1 million …

Strong Fundamentals Position Kratos Defense & Security Solutions (KTOS) for Long-Term Upside

Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Discovery Fund". A copy of the letter is available to download here. Baron Discovery Fund appreciated by 19.08% (Institutional Shares) in the quarter, underperforming the Russell 2000 Growth Index, …

Eaton Corporation stock analysis: valuation debate as ETN hits all-time highs

Eaton Corporation (ETN) has reached all-time highs, driven by strong Q2 2026 results, increased guidance, and its strategic positioning as an AI infrastructure provider. While bullish analysts foresee continued growth, InvestingPro's Fair Value model suggests a significant downside, leading to a valuation debate. Investors …

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

Which Precious Metals ETF Is the Better Buy: Global X's Silver Miners SIL or iShares' Gold Trust IAU?

Key Points iShares Gold Trust tracks physical gold prices, while Global X - Silver Miners ETF provides exposure to mining stocks. iShares Gold Trust features a lower expense ratio and significantly lower volatility compared to Global X - Silver Miners ETF. Global X - …

CAPLIPOINT: 20% revenue growth, strong margins, and major capacity expansion drive future outlook

Forget Buying Gold Directly: Wheaton Precious Metals Could Be the Better Play.

It's not quite a first-to-worst story, but after shining last year, gold has lost considerable luster in 2026. Thanks to a strong start to August, the SPDR Gold Shares and other gold ETFs backed by physical holdings of the commodity are sporting modest year-to-date …